• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.

作者信息

Ismail Sherin, Funk Michele Jonsson, Flythe Jennifer E

机构信息

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina (UNC) at Chapel Hill, Chapel Hill, North Carolina.

UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina.

出版信息

J Am Soc Nephrol. 2024 Aug 1;35(8):1136. doi: 10.1681/ASN.0000000000000386. Epub 2024 May 20.

DOI:10.1681/ASN.0000000000000386
PMID:38767970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11377790/
Abstract
摘要

相似文献

1
Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.作者回复：药代动力学问题可能会影响接受慢性血液透析患者中昂丹司琼所带来的心脏风险认知。
J Am Soc Nephrol. 2024 Aug 1;35(8):1136. doi: 10.1681/ASN.0000000000000386. Epub 2024 May 20.
2
Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.药代动力学问题可能会影响接受慢性血液透析患者中昂丹司琼所致的心脏风险认知。
J Am Soc Nephrol. 2024 Aug 1;35(8):1134-1135. doi: 10.1681/ASN.0000000000000385. Epub 2024 May 20.
3
Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis.昂丹司琼与维持性血液透析患者中心性猝死风险。
J Am Soc Nephrol. 2024 Jun 1;35(6):761-771. doi: 10.1681/ASN.0000000000000336. Epub 2024 Feb 27.
4
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.用于减少儿童和青少年急性胃肠炎相关呕吐的止吐药。
Cochrane Database Syst Rev. 2009 Apr 15(2):CD005506. doi: 10.1002/14651858.CD005506.pub4.
5
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.用于减少儿童和青少年急性胃肠炎相关呕吐的止吐药。
Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD005506. doi: 10.1002/14651858.CD005506.pub5.
6
Intraperitoneal ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on peritoneal dialysis.腹膜内注射盐酸昂丹司琼用于治疗一名腹膜透析患者因糖尿病胃轻瘫所致的顽固性恶心和呕吐。
Perit Dial Int. 2002 Jul-Aug;22(4):539-40.
7
[5HT3 antagonists: ondansetron].[5-羟色胺3拮抗剂：昂丹司琼]
Rev Med Univ Navarra. 1993 Jan-Mar;38(1):43-9.
8
Ondansetron - falsely accused?昂丹司琼——被错误指控了？
Paediatr Anaesth. 2000;10(3):343.
9
Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.雷莫司琼在外科手术患者中的群体药代动力学及预防性止吐疗效
Br J Clin Pharmacol. 2016 Sep;82(3):762-72. doi: 10.1111/bcp.13010. Epub 2016 Jun 8.
10
Ondansetron looks safe in pregnancy, so far.到目前为止，昂丹司琼在孕期似乎是安全的。
BMJ. 2013 Mar 6;346:f1387. doi: 10.1136/bmj.f1387.

本文引用的文献

1
Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.药代动力学问题可能会影响接受慢性血液透析患者中昂丹司琼所致的心脏风险认知。
J Am Soc Nephrol. 2024 Aug 1;35(8):1134-1135. doi: 10.1681/ASN.0000000000000385. Epub 2024 May 20.
2
Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis.昂丹司琼与维持性血液透析患者中心性猝死风险。
J Am Soc Nephrol. 2024 Jun 1;35(6):761-771. doi: 10.1681/ASN.0000000000000336. Epub 2024 Feb 27.
3
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.质子泵抑制剂可能会增加接受血液透析的患者使用西酞普兰和艾司西酞普兰相关的心脏性猝死风险。
Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):670-679. doi: 10.1002/pds.5428. Epub 2022 Mar 24.